Author:
Kreuz Wolfhart,Ettingshausen Carmen Escuriola
Reference54 articles.
1. Epidemiology of inhibitors and current treatment strategies;Kreuz;Haematologica,2003
2. Recombinant vs. plasma-derived products, especially those with intact VWF, regarding inhibitor development;Escuriola-Ettingshausen;Haemophilia,2006
3. Cost of care and quality of life for patients with haemophilia complicated by inhibitors: the COCIS study group;Gringeri;Blood,2003
4. Inhibitor incidence in previously untreated patients (PUPs) with hemophilia A and B. A prospective multi-center study of the Pediatric Committee of the German, Swiss and Austrian Society for Thrombosis and Hemostasis Research (GTH);Kreuz,2005
5. Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs;Ehrenforth;Lancet,1992
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献